These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34632822)

  • 1. Falling Through the Cracks: The Current Gap in the Health Care Transition of Patients With Kawasaki Disease: A Scientific Statement From the American Heart Association.
    Dahdah N; Kung SC; Friedman KG; Marelli A; Gordon JB; Belay ED; Baker AL; Kazi DS; White PH; Tremoulet AH;
    J Am Heart Assoc; 2021 Oct; 10(20):e023310. PubMed ID: 34632822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.
    McCrindle BW; Rowley AH; Newburger JW; Burns JC; Bolger AF; Gewitz M; Baker AL; Jackson MA; Takahashi M; Shah PB; Kobayashi T; Wu MH; Saji TT; Pahl E;
    Circulation; 2017 Apr; 135(17):e927-e999. PubMed ID: 28356445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-care transition after Kawasaki disease in patients with coronary artery lesion.
    Kamiyama H; Ayusawa M; Ogawa S; Saji T; Hamaoka K
    Pediatr Int; 2018 Mar; 60(3):232-239. PubMed ID: 29290099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-of-the-art acute phase management of Kawasaki disease after 2017 scientific statement from the American Heart Association.
    Liu YC; Lin MT; Wang JK; Wu MH
    Pediatr Neonatol; 2018 Dec; 59(6):543-552. PubMed ID: 29706362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, Clinical Presentation, and Outcomes of Kawasaki Disease Among Hospitalized Children in an Inner City Hospital Before and After Publication of the American Academy of Pediatrics/American Heart Association Guidelines for Treatment of Kawasaki Disease: An 11-Year Period.
    Sehgal S; Chen X; Ang JY
    Clin Pediatr (Phila); 2015 Nov; 54(13):1283-9. PubMed ID: 26134553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association.
    Ferriero DM; Fullerton HJ; Bernard TJ; Billinghurst L; Daniels SR; DeBaun MR; deVeber G; Ichord RN; Jordan LC; Massicotte P; Meldau J; Roach ES; Smith ER;
    Stroke; 2019 Mar; 50(3):e51-e96. PubMed ID: 30686119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades.
    Osborne J; Friedman K; Runeckles K; Choueiter NF; Giglia TM; Dallaire F; Newburger JW; Low T; Mathew M; Mackie AS; Dahdah N; Yetman AT; Harahsheh AS; Raghuveer G; Norozi K; Burns JC; Jain S; Mondal T; Portman MA; Szmuszkovicz JR; Crean A; McCrindle BW;
    Pediatr Cardiol; 2021 Mar; 42(3):676-684. PubMed ID: 33439285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Wijdicks EF; Sheth KN; Carter BS; Greer DM; Kasner SE; Kimberly WT; Schwab S; Smith EE; Tamargo RJ; Wintermark M;
    Stroke; 2014 Apr; 45(4):1222-38. PubMed ID: 24481970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Managing Transition to Adulthood for Adolescents With Congenital Heart Disease: A Practical Approach to Transition Program Design: A Scientific Statement From the American Heart Association.
    John AS; Jackson JL; Moons P; Uzark K; Mackie AS; Timmins S; Lopez KN; Kovacs AH; Gurvitz M;
    J Am Heart Assoc; 2022 Apr; 11(7):e025278. PubMed ID: 35297271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Kawasaki disease in adults.
    Denby KJ; Clark DE; Markham LW
    Heart; 2017 Nov; 103(22):1760-1769. PubMed ID: 28751537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.
    Yellen ES; Gauvreau K; Takahashi M; Burns JC; Shulman S; Baker AL; Innocentini N; Zambetti C; Pancheri JM; Ostrow A; Frazer JR; Sundel RP; Fulton DR; Newburger JW
    Pediatrics; 2010 Feb; 125(2):e234-41. PubMed ID: 20100771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care transition in pediatric neurosurgery: a consensus statement from the American Society of Pediatric Neurosurgeons.
    Rocque BG; Weprin BE; Blount JP; Hopson BD; Drake JM; Hamilton MG; Williams MA; White PH; Orrico KO; Martin JE
    J Neurosurg Pediatr; 2020 May; 25(5):555-563. PubMed ID: 32059192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing healthcare transitions in the medical home: tools for providers, families and adolescents with special healthcare needs.
    Lemly DC; Weitzman ER; O'Hare K
    Curr Opin Pediatr; 2013 Aug; 25(4):439-46. PubMed ID: 23770924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.
    McCrindle BW; Manlhiot C; Newburger JW; Harahsheh AS; Giglia TM; Dallaire F; Friedman K; Low T; Runeckles K; Mathew M; Mackie AS; Choueiter NF; Jone PN; Kutty S; Yetman AT; Raghuveer G; Pahl E; Norozi K; McHugh KE; Li JS; De Ferranti SD; Dahdah N;
    J Am Heart Assoc; 2020 Aug; 9(15):e016440. PubMed ID: 32750313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki disease: patients' transition journey and recommendations for adult care.
    Chahal N; Rush J; Lardizabal A; Nobile R; Delayun C; Collins T; Thorne S; McCrindle BW
    Cardiol Young; 2024 Apr; 34(4):793-802. PubMed ID: 37830370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care transition from pediatric to adult care: an evidence-based guideline.
    Pape L; Ernst G
    Eur J Pediatr; 2022 May; 181(5):1951-1958. PubMed ID: 35084548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime cardiovascular management of patients with previous Kawasaki disease.
    Brogan P; Burns JC; Cornish J; Diwakar V; Eleftheriou D; Gordon JB; Gray HH; Johnson TW; Levin M; Malik I; MacCarthy P; McCormack R; Miller O; Tulloh RMR;
    Heart; 2020 Mar; 106(6):411-420. PubMed ID: 31843876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines.
    Ghelani SJ; Sable C; Wiedermann BL; Spurney CF
    Pediatr Cardiol; 2012 Oct; 33(7):1097-103. PubMed ID: 22349679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
    Dionne A; Meloche-Dumas L; Desjardins L; Turgeon J; Saint-Cyr C; Autmizguine J; Spigelblatt L; Fournier A; Dahdah N
    Pediatr Int; 2017 Mar; 59(3):265-270. PubMed ID: 27589358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA;
    Pediatrics; 2004 Dec; 114(6):1708-33. PubMed ID: 15574639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.